KAYLA MARTELLO: Open Payments
NPI 1154000180 · HARTFORD, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$494 in 4 payments from 4 companies in 2025. Trend: 2023 $125 · 2024 $80 · 2025 $494
Food & beverage: $494
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 1 | $125 |
| Incyte Corporation | 1 | $125 |
| E.R. Squibb & Sons, L.L.C. | 1 | $122 |
| Astellas Pharma US Inc | 1 | $122 |
Products named: IMFINZI, Jakafi, REBLOZYL, Vyloy.
Industry payments across CT — which companies pay providers there.
